CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-21 | Edris Badreddin Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,605 | 0 | ||
| 2026-01-21 | Edris Badreddin Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −17,236 | 0 | ||
| 2026-01-21 | Edris Badreddin Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −13,690 | 0 | ||
| 2026-01-02 | Fox Jonathan C Director | Grant or award | +473 | 24,175 | ||
| 2025-11-19 | Martin Christopher Nathan Director | Grant or award · Stock Options (Right to buy) | +45,150 | 45,150 | ||
| 2025-11-12 | Russell Alan J Chief Scientific Officer | Option exercise | +100,000 | $0.18 | $18K | 123,400 |
| 2025-11-12 | Russell Alan J Chief Scientific Officer | Sale | −100,000 | $21.12 | $2.1M | 23,400 |
| 2025-11-12 | Russell Alan J Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −100,000 | 1,147,365 | ||
| 2025-11-11 | Fox Jonathan C Director | Purchase | +10,700 | $18.64 | $199K | 23,702 |
| 2025-11-10 | Nofi Michael Chief Financial Officer | Grant or award · Restricted Stock Units | +43,750 | 43,750 | ||
| 2025-11-10 | Nofi Michael Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +262,500 | 262,500 | ||
| 2025-10-01 | Fox Jonathan C Director | Grant or award | +728 | 13,002 | ||
| 2025-08-26 | Russell Alan J Chief Scientific Officer | Option exercise | +100,000 | $0.18 | $18K | 123,400 |
| 2025-08-26 | Russell Alan J Chief Scientific Officer | Sale | −100,000 | $14.60 | $1.5M | 23,400 |
| 2025-08-26 | Russell Alan J Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −100,000 | 1,247,365 | ||
| 2025-08-12 | Blaustein Robert Chief Development Officer | Grant or award · Restricted Stock Units | +17,500 | 17,500 | ||
| 2025-08-12 | Blaustein Robert Chief Development Officer | Grant or award · Stock Options (Right to buy) | +105,000 | 105,000 | ||
| 2025-08-12 | MOORE JOHN R General Counsel | Option exercise | +5,781 | 12,312 | ||
| 2025-08-12 | MOORE JOHN R General Counsel | Sale | −2,098 | $13.39 | $28K | 10,214 |
| 2025-08-12 | MOORE JOHN R General Counsel | Option exercise · Restricted Stock Units | −5,781 | 17,344 |
Page 6 of 26 · 509 trades